Overview

Effectiveness of Ketamine in Malignant Neuropathic Pain Relief

Status:
Withdrawn
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
To see whether the addition of low-dose ketamine to a subcutaneous morphine infusion improves analgesia in patients with neuropathic cancer pain.
Phase:
Phase 3
Details
Lead Sponsor:
Haukeland University Hospital
Treatments:
Ketamine